Medtronic Plc(MDT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 22.56 | EPS (ttm) | 4.06 | Insider Own | 0.09% | Shs Outstand | 1.28B | Perf Week | -0.61% |
| Market Cap | 117.19B | Forward P/E | 14.32 | EPS next Y | 7.14% | Insider Trans | -0.63% | Shs Float | 1.28B | Perf Month | 1.04% |
| Enterprise Value | 137.15B | PEG | 1.83 | EPS next Q | 1.33 | Inst Own | 89.08% | Short Float | 1.12% | Perf Quarter | 14.17% |
| Income | 5.23B | P/S | 3.12 | EPS this Y | 8.02% | Inst Trans | -1.66% | Short Ratio | 1.76 | Perf Half Y | 2.98% |
| Sales | 37.54B | P/B | 2.33 | EPS next 5Y | 7.82% | ROA | 5.68% | Short Interest | 14.35M | Perf YTD | -4.62% |
| Book/sh | 39.24 | P/C | 13.29 | EPS past 3/5Y | 9.75% 6.95% | ROE | 10.66% | 52W High | -13.83% ($106.33) | Perf Year | -0.76% |
| Cash/sh | 6.89 | P/FCF | 19.11 | Sales past 3/5Y | 5.21% 3.84% | ROIC | 6.9% | 52W Low | 24.98% ($73.31) | Perf 3Y | 14.58% |
| Dividend Est. | $2.89 (3.16%) | EV/EBITDA | 13.16 | EPS Y/Y TTM | 12.28% | Gross Margin | 60.56% | Volatility(W/M) | 2.59% 2.26% | Perf 5Y | -30.14% |
| Dividend TTM | 2.85 | EV/Sales | 3.65 | Sales Y/Y TTM | 9.77% | Oper. Margin | 19.93% | ATR (14) | 2.25 | Perf 10Y | 7.95% |
| Dividend Ex-Date | 2026/9/25 | Quick Ratio | 1.54 | EPS Q/Q | 41.57% | Profit Margin | 13.93% | RSI (14) | 54.16 | Recom | 1.71 |
| Dividend Gr. 3/5Y | 1.45% 4.13% | Current Ratio | 2.07 | Sales Q/Q | 13.73% | SMA20 | -0.39% ($91.98) | Beta | 0.56 | Target Price | $104.78 |
| Payout | 76.2% | Debt/Eq | 0.56 | Earnings | 2026/9/1 | SMA50 | 4.77% ($87.45) | Rel Volume | 0.6 | Prev Close | $91.89 |
| Employees | 95000 | LT Debt/Eq | 0.51 | EPS/Sales Surpr. | 4.44% 2.2% | SMA200 | 2.26% ($89.6) | Avg Volume(3M) | 8.15M | Price | $91.62 |
| IPO | 1977/11/21 | Option/Short | Yes/Yes | Trades | 51554 | Volume | 4,922,982 | Change | -0.29% |
Company
MDT is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩺 A global medical device conglomerate with an extensive portfolio spanning cardiovascular, neuroscience, surgical, and diabetes care. Founded in the United States in 1949 and headquartered in Ireland, it is a comprehensive medical device group holding a leading position in the global medical device market.
Over the past 1 year, roughly in the middle
14% below its 1-year high.
Upcoming eventsNext ex-dividend (upcoming)
Ex-dividend September 25
MDT makes money exceptionally well
19.93% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +8.0% this year.
Tap to view numbers
The price looks about right
Trading at 22.6 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +14.6% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 3.16% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 89.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
ABEQ 0.05%
IHI 0.04%
MAVF 0.03%
CAMX 0.03%
GAUD 0.03%It ranks #2 in the industry
Based on market cap of $117B.
MDT $117B PER 22.6
ABT $179B PER 33.4
SYK $104B PER 28.0
BSX $62B PER 17.5
FAQ
What kind of company is MDT?
MDT belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of MDT?
The market cap of MDT is approximately $117.2B, ranking 134 within its sector.
Does MDT pay dividends?
MDT has a dividend yield of approximately 3.16%, with an annual dividend of $2.89.
What is the P/E ratio of MDT?
MDT has a P/E ratio of approximately 22.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for MDT?
MDT has recorded a 52-week high of $106.33 and a low of $73.31.
